FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Antonio D'Avolio

Research Profile

Disorders

HIV Infections

Chemicals & Drugs

Procedures

Concepts & Ideas

Physiology

Drug Interactions

Living Beings

HIV-1

Co-author Network

Publications

TOP 3
Antonio D'Avolio; Silvia De Francia; Francesca De Martino; Giovanni Di Perri; Francesca Piccione; Elisa Pirro; Arianna Ardito; Vittoria Basile; Jessica Cusato; Marco Volante; Barbara Zaggia; Massimo Terzolo
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane.
Francesco G De Rosa; Giovanni Di Perri; V Marco Ranieri; Alessandra Ariaudo; Lorena Baietto; Silvia Corcione; Antonio D'Avolio
Pharmacokinetics of linezolid during extracorporeal membrane oxygenation.
Antonio D'Avolio; Amedeo De Nicolò; Danilo Agnesod; Lucio Boglione; Giuseppe Cariti; Sujan Dilly Penchala; Adnan Mohamed Abdi; Marco Simiele; Giovanni Di Perri
A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Antonio D'Avolio (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Antonio D'Avolio; Silvia De Francia; Francesca De Martino; Giovanni Di Perri; Francesca Piccione; Elisa Pirro; Arianna Ardito; Vittoria Basile; Jessica Cusato; Marco Volante; Barbara Zaggia; Massimo Terzolo
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane.
Pharmacogenetics and genomics 2013;23(6):293-300.
2013: Francesco G De Rosa; Giovanni Di Perri; V Marco Ranieri; Alessandra Ariaudo; Lorena Baietto; Silvia Corcione; Antonio D'Avolio
Pharmacokinetics of linezolid during extracorporeal membrane oxygenation.
International journal of antimicrobial agents 2013;41(6):590-1.
2013: Antonio D'Avolio; Amedeo De Nicolò; Danilo Agnesod; Lucio Boglione; Giuseppe Cariti; Sujan Dilly Penchala; Adnan Mohamed Abdi; Marco Simiele; Giovanni Di Perri
A UPLC-MS/MS method for the simultaneous plasma quantification of all isomeric forms of the new anti-HCV protease inhibitors boceprevir and telaprevir.
Journal of pharmaceutical and biomedical analysis 2013;78-79():217-23.
2013: L Boglione; Giuseppe Cariti; Antonio D'Avolio; A De Nicolò; Valeria Ghisetti; M G Milia; M Simiele; G Di Perri
Sequential therapy with entecavir and PEG-INF in patients affected by chronic hepatitis B and high levels of HBV-DNA with non-D genotypes.
Journal of viral hepatitis 2013;20(4):e11-9.
2013: Andrea Calcagno; Antonio D'Avolio; Giovanni Di Perri; D Gonzalez de Requena; V Libanore; I Motta; G Orofino; E Orsucci; Bernardino Salassa; M Simiele; M C Tettoni; P Bigliano; C Bramato; Stefano Bonora
Tenofovir plasma concentrations according to companion drugs: a cross-sectional study of HIV-positive patients with normal renal function.
Antimicrobial agents and chemotherapy 2013;57(4):1840-3.
2013: Lucio Boglione; Elisa Burdino; Giuseppe Cariti; Jessica Cusato; Antonio D'Avolio; Francesco G De Rosa; Valeria Ghisetti; Gabriella Gregori; Lorena Baietto; Giovanni Di Perri
Kinetics and prediction of HBsAg loss during therapy with analogues in patients affected by chronic hepatitis B HBeAg negative and genotype D.
Liver international : official journal of the International Association for the Study of the Liver 2013;33(4):580-5.
2013: Dinko Rekic; Daniel Röshammar; Joel Tarning; Marie Vigan; Michael Ashton; Aurélie Barrail-Tran; Martin Bergstrand; Andrea Calcagno; Antonio D'Avolio; Magnus Gisslen; Vidar Ormaasen; Angela Abelö
External validation of the bilirubin-atazanavir nomogram for assessment of atazanavir plasma exposure in HIV-1-infected patients.
The AAPS journal 2013;15(2):308-15.
2013: Antonio D'Avolio; Giovanni Di Perri; Giovanna Larovere; Mauro Sciandra; Marco Siccardi; Marco Simiele; Mariacristina Tettoni; Laura Trentini; Silvia Agati; Lorena Baietto; Andrea Calcagno; Jessica Cusato; Stefano Bonora
Intracellular accumulation of ritonavir combined with different protease inhibitors and correlations between concentrations in plasma and peripheral blood mononuclear cells.
The Journal of antimicrobial chemotherapy 2013;68(4):907-10.
2013: Lucio Boglione; Giuseppe Cariti; Antonio D'Avolio; Giovanni Di Perri
Telbivudine in the treatment of hepatitis B-associated cryoglobulinemia.
Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2013;56(2):167-9.
2013: Andrea Calcagno; Antonio D'Avolio; Giovanni Di Perri; C Montrucchio; M Simiele; M C Tettoni; Laura Trentini; Stefano Bonora
Pharmacokinetics of 400 mg of raltegravir once daily in combination with atazanavir/ritonavir plus two nucleoside/nucleotide reverse transcriptase inhibitors.
The Journal of antimicrobial chemotherapy 2013;68(2):482-4.
2013: Andrea Marengo; Milena Marietti; Mario Rizzetto; Pierluigi Toniutto; Davide Bitetto; Alessia Ciancio; Antonio D'Avolio; Giovanni Di Perri; Carlo Fabris; Alfredo Marzano
Clinical and virological response to entecavir in HBV-related chronic hepatitis or cirrhosis: data from the clinical practice in a single-centre cohort.
Antiviral therapy 2013;18(1):87-94.
2012: Lorena Baietto; Jessica Cusato; Antonio D'Avolio; Francesco Giuseppe De Rosa; Cristina Marra; Simone Pace; Marco Simiele; Alessandra Ariaudo; Giovanni Di Perri
Development and validation of a new method to simultaneously quantify triazoles in plasma spotted on dry sample spot devices and analysed by HPLC-MS.
The Journal of antimicrobial chemotherapy 2012;67(11):2645-9.
2012: francesco giuseppe de rosa; Daniela Pasero; S Raviolo; Mauro Rinaldi; L Baietto; Paolo Centofanti; S Corcione; Antonio D'Avolio; Giovanni Di Perri
Anidulafungin for Candida glabrata infective endocarditis.
Antimicrobial agents and chemotherapy 2012;56(8):4552-3.
2012: Andrea Calcagno; Jessica Cusato; Antonio D'Avolio; Giovanni Di Perri; Letizia Marinaro; Marco Siccardi; Marco Simiele; Aylin Yilmaz; Roberto Bertucci; Stefano Bonora
Determinants of darunavir cerebrospinal fluid concentrations: impact of once-daily dosing and pharmacogenetics.
AIDS (London, England) 2012;26(12):1529-33.
2012: Andrea Calcagno; Jessica Cusato; Antonio D'Avolio; Valentina Libanore; Roberto Rostagno; Marco Siccardi; Marco Simiele; Lorena Baietto; Stefano Bonora; Giovanni Di Perri
Influence of CYP2B6 and ABCB1 SNPs on nevirapine plasma concentrations in Burundese HIV-positive patients using dried sample spot devices.
British journal of clinical pharmacology 2012;74(1):134-40.
2012: Antonio D'Avolio; Amedeo De Nicolò; Giovanni Di Perri; Mauro Sciandra; Marco Simiele; Stefano Turini; Danilo Agnesod; Lorena Baietto; Lucio Boglione; Andrea Calcagno; Giuseppe Cariti; Jessica Cusato; Stefano Bonora
Development and validation of a useful HPLC-UV method for quantification of total and phosphorylated-ribavirin in blood and erythrocytes of HCV+ patients.
Journal of pharmaceutical and biomedical analysis 2012;66():376-80.
2012: Antonio D'Avolio; Silvia De Francia; Francesco Di Carlo; Alessandra Ariaudo; Lorena Baietto; Jessica Cusato; Carmen Fava; Giuseppe Saglio; Marco Simiele; Giovanni Di Perri
HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC).
Journal of pharmaceutical and biomedical analysis 2012;59():109-16.
2012: Stefano Bonora; Andrea Calcagno; C Cometto; Ivano Dal Conte; Antonio D'Avolio; S Fontana; D Gonzalez de Requena; Anna Lucchini; Agostino Maiello; D Aguilar; Giovanni Di Perri
Short-term additional enfuvirtide therapy is associated with a greater immunological recovery in HIV very late presenters: a controlled pilot study.
Infection 2012;40(1):69-75.
2011: Antonio D'Avolio; Lorena Baietto; Stefano Bonora; Andrea Calcagno; Giuseppe Cariti; Alessia Ciancio; Jessica Cusato; Mario Rizzetto; Marco Siccardi; Marco Simiele; Antonina Smedile; Giovanni Di Perri
Ribavirin pharmacokinetics and interleukin 28B plus cytochrome P450 27B1 single-nucleotide polymorphisms as predictors of response to pegylated interferon/ribavirin treatment in patients infected with hepatitis C virus genotype 1/4.
Hepatology (Baltimore, Md.) 2011;54(6):2278-9.
2011: Andrea Calcagno; Antonella Castagna; Antonio D'Avolio; Daniel Gonzalez de Requena; Adriano Lazzarin; Silvia Nozza; Stefano Bonora; Giovanni Di Perri
Pharmacokinetics of the raltegravir/maraviroc/etravirine combination.
The Journal of antimicrobial chemotherapy 2011;66(8):1932-4.
2011: Andrea Calcagno; Antonio D'Avolio; Marino Bonasso; Stefano Bonora; Daniele Imperiale; Alessandra Romito; Roberto Rostagno; Marco Simiele; Maria C Tettoni; Giovanni Di Perri
Tenofovir and emtricitabine cerebrospinal fluid-to-plasma ratios correlate to the extent of blood-brainbarrier damage.
AIDS (London, England) 2011;25(11):1437-9.
2011: Silvia Garazzino; Alessandro Aprato; Lorena Baietto; Antonio D'Avolio; Agostino Maiello; Domenico Aloj; Marco Siccardi; Antonio Biasibetti; Alessandro Massè; Francesco Giuseppe De Rosa; Giovanni Di Perri
Ceftriaxone bone penetration in patients with septic non-union of the tibia.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2011;15(6):e415-21.
2011: Marco Simiele; Antonio D'Avolio; Lorena Baietto; Marco Siccardi; Mauro Sciandra; Silvia Agati; Jessica Cusato; Stefano Bonora; Giovanni Di Perri
Evaluation of the mean corpuscular volume of peripheral blood mononuclear cells of HIV patients by a coulter counter to determine intracellular drug concentrations.
Antimicrobial agents and chemotherapy 2011;55(6):2976-8.
2011: Akil Jackson; Antonio D'Avolio; Victoria Watson; Stefano Bonora; David Back; Jessica Taylor; Kostantinos Armenis; Brian Gazzard; Graeme Moyle; Marta Boffito
Pharmacokinetics and safety of the co-administration of the antiretroviral raltegravir and the lipid-lowering drug ezetimibe in healthy volunteers.
The Journal of antimicrobial chemotherapy 2011;66(4):885-9.
2011: Antonio D'Avolio; Marco Simiele; Marco Siccardi; Lorena Baietto; Mauro Sciandra; Valentina Oddone; Francesca Romana Stefani; Silvia Agati; Jessica Cusato; Stefano Bonora; Giovanni Di Perri
A HPLC-MS method for the simultaneous quantification of fourteen antiretroviral agents in peripheral blood mononuclear cell of HIV infected patients optimized using medium corpuscular volume evaluation.
Journal of pharmaceutical and biomedical analysis 2011;54(4):779-88.
2011: Stefano Bonora; Andrea Calcagno; Antonio D'Avolio; Daniel Gonzalez de Requena; Marco Siccardi; Marco Simiele; Mariacristina Tettoni; Laura Trentini; Lorena Baietto; Giovanni Di Perri
Pharmacokinetics of switching unboosted atazanavir coadministered with tenofovir disoproxil fumarate from 400 mg once daily to 200 mg twice daily in HIV-positive patients.
Antiviral therapy 2011;16(4):499-504.
2011: Chiara Tommasi; Emanuele Nicastri; Leopoldo Paolo Pucillo; Massimo Tempestilli; Rita Bellagamba; Antonio D'Avolio; Anna L Gallo; Jelena Ivanovic; Pasquale Narciso
Marked increase in etravirine and saquinavir plasma concentrations during atovaquone/proguanil prophylaxis.
Malaria journal 2011;10():141.
2011: Daniel Gonzalez de Requena; Stefano Bonora; Ottavia Viganò; Andrea Calcagno; Cristina Cometto; Antonio D'Avolio; Lorena Baietto; Valeria Ghisetti; Silvia Magnani; Stefania Ferramosca; Paola Vitiello; Massimo Galli; Stefano Rusconi; Giovanni Di Perri
Comparative evaluation of seven resistance interpretation algorithms and their derived genotypic inhibitory quotients for the prediction of 48 week virological response to darunavir-based salvage regimens.
The Journal of antimicrobial chemotherapy 2011;66(1):192-200.
2011: Andrea Calcagno; L Baietto; francesco giuseppe de rosa; M C Tettoni; V Libanore; R Bertucci; Antonio D'Avolio; Giovanni Di Perri
Posaconazole cerebrospinal concentrations in an HIV-infected patient with brain mucormycosis.
The Journal of antimicrobial chemotherapy 2011;66(1):224-5.
2010: Aylin Yilmaz; Antonio D'Avolio; Dietmar Fuchs; Lars Hagberg; Bo Svennerholm; Chris Verhofstede; Victoria Watson; Magnus Gisslen
Treatment intensification has no effect on the HIV-1 central nervous system infection in patients on suppressive antiretroviral therapy.
Journal of acquired immune deficiency syndromes (1999) 2010;55(5):590-6.
2010: Marco Siccardi; Antonio D'Avolio; Silvia Nozza; Marco Simiele; Lorena Baietto; Francesca Romana Stefani; Darren Moss; Wai-San Kwan; Antonella Castagna; Adriano Lazzarin; Andrea Calcagno; Stefano Bonora; David Back; Giovanni Di Perri; Andrew Owen
Maraviroc is a substrate for OATP1B1 in vitro and maraviroc plasma concentrations are influenced by SLCO1B1 521 T>C polymorphism.
Pharmacogenetics and genomics 2010;20(12):759-65.
2010: Alessandro Schipani; Marco Siccardi; Antonio D'Avolio; Lorena Baietto; Marco Simiele; Stefano Bonora; Sonia Rodríguez-Novoa; Lorena Cuenca; Vincent Soriano; Nitipatana Chierakul; Natpratou Saguenwong; Charoen Chuchuttaworn; Janelle M Hoskins; Anne M Dvorak; Howard L McLeod; Gerry Davies; Saye Khoo; David J Back; Giovanni Di Perri; Andrew Owen
Population pharmacokinetic modeling of the association between 63396C->T pregnane X receptor polymorphism and unboosted atazanavir clearance.
Antimicrobial agents and chemotherapy 2010;54(12):5242-50.
2010: Antonio D'Avolio; Marco Simiele; Marco Siccardi; Lorena Baietto; Mauro Sciandra; Stefano Bonora; Giovanni Di Perri
HPLC-MS method for the quantification of nine anti-HIV drugs from dry plasma spot on glass filter and their long term stability in different conditions.
Journal of pharmaceutical and biomedical analysis 2010;52(5):774-80.
2010: Andrea Calcagno; R Rostagno; Sabrina Audagnotto; Antonio D'Avolio; Stefano Bonora; Valeria Ghisetti; Giovanni Di Perri
Is peritoneal fluid a sanctuary site for HIV?
The Journal of antimicrobial chemotherapy 2010;65(9):2052-3.
2010: Lorena Baietto; Antonio D'Avolio; Giusi Ventimiglia; Francesco Giuseppe De Rosa; Marco Siccardi; Marco Simiele; Mauro Sciandra; Giovanni Di Perri
Development, validation, and routine application of a high-performance liquid chromatography method coupled with a single mass detector for quantification of itraconazole, voriconazole, and posaconazole in human plasma.
Antimicrobial agents and chemotherapy 2010;54(8):3408-13.
2010: Andrea Calcagno; Stefano Bonora; Antonio D'Avolio; Marco Siccardi; Marco Simiele; Mattia Chiesa; Daniel Gonzalez de Requena; Giovanni Di Perri
Raltegravir penetration in seminal plasma of healthy volunteers.
Antimicrobial agents and chemotherapy 2010;54(6):2744-5.
2010: Sonia Rodríguez-Nóvoa; Pablo Labarga; Antonio D'Avolio; Pablo Barreiro; Marta Albalate; Eugenia Vispo; Carmen Solera; Marco Siccardi; Stefano Bonora; Giovanni Di Perri; Vincent Soriano
Impairment in kidney tubular function in patients receiving tenofovir is associated with higher tenofovir plasma concentrations.
AIDS (London, England) 2010;24(7):1064-6.
2010: Andrea Calcagno; Stefano Bonora; Roberto Bertucci; Anna Lucchini; Antonio D'Avolio; Giovanni Di Perri
Raltegravir penetration in the cerebrospinal fluid of HIV-positive patients.
AIDS (London, England) 2010;24(6):931-2.
2010: Antonio D'Avolio; Marco Simiele; Lorena Baietto; Marco Siccardi; Mauro Sciandra; Samantha Patanella; Stefano Bonora; Giovanni Di Perri
A validated high-performance liquid chromatography-ultraviolet method for quantification of the CCR5 inhibitor maraviroc in plasma of HIV-infected patients.
Therapeutic drug monitoring 2010;32(1):86-92.
2010: Lorena Baietto; Antonio D'Avolio; Francesco Giuseppe De Rosa; Silvia Garazzino; Marianna Michelazzo; Giusi Ventimiglia; Marco Siccardi; Marco Simiele; Mauro Sciandra; Giovanni Di Perri
Development and validation of a simultaneous extraction procedure for HPLC-MS quantification of daptomycin, amikacin, gentamicin, and rifampicin in human plasma.
Analytical and bioanalytical chemistry 2010;396(2):791-8.
2009: Andrea Calcagno; Stefano Bonora; Maria Cristina Tettoni; Antonio D'Avolio; Giovanni Di Perri; Massimiliano Lanzafame; Giovanni Penco
Tenofovir coadministration is not associated with lower unboosted atazanavir plasma exposure in the clinical setting.
Journal of acquired immune deficiency syndromes (1999) 2009;52(3):431-2.
2009: Giovanni Guaraldi; Stefania Cocchi; A Motta; S Ciaffi; C Conti; Mauro Codeluppi; Stefano Bonora; S Zona; Fabrizio Di Benedetto; Diego Pinetti; Antonio D'Avolio; Alfio Bertolini; Roberto Esposito
Differential dose adjustments of immunosuppressants after resuming boosted versus unboosted HIV-protease inhibitors postliver transplant.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2009;9(10):2429-34.
2009: Antonio Di Biagio; Raffaella Rosso; Marco Siccardi; Antonio D'Avolio; Stefano Bonora; Claudio Viscoli
Lack of interaction between raltegravir and cyclosporin in an HIV-infected liver transplant recipient.
The Journal of antimicrobial chemotherapy 2009;64(4):874-5.
2009: Silvia De Francia; Antonio D'Avolio; Francesca De Martino; Elisa Pirro; Lorena Baietto; Marco Siccardi; Marco Simiele; Silvia Racca; Giuseppe Saglio; Francesco Di Carlo; Giovanni Di Perri
New HPLC-MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib, and nilotinib in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2009;877(18-19):1721-6.
2009: Lorena Baietto; Antonio D'Avolio; francesco giuseppe de rosa; Silvia Garazzino; Samantha Patanella; Marco Siccardi; Mauro Sciandra; Giovanni Di Perri
Simultaneous quantification of linezolid, rifampicin, levofloxacin, and moxifloxacin in human plasma using high-performance liquid chromatography with UV.
Therapeutic drug monitoring 2009;31(1):104-9.
2008: Antonio D'Avolio; Lorena Baietto; Marco Siccardi; Mauro Sciandra; Marco Simiele; Valentina Oddone; Stefano Bonora; Giovanni Di Perri
An HPLC-PDA method for the simultaneous quantification of the HIV integrase inhibitor raltegravir, the new nonnucleoside reverse transcriptase inhibitor etravirine, and 11 other antiretroviral agents in the plasma of HIV-infected patients.
Therapeutic drug monitoring 2008;30(6):662-9.
2008: Giovanni Guaraldi; Stefania Cocchi; Alice Motta; Sara Ciaffi; Mauro Codeluppi; Stefano Bonora; Fabrizio Di Benedetto; Michele Masetti; Marco Floridia; Silvia Baroncelli; Diego Pinetti; Antonio D'Avolio; Alfio Bertolini; Roberto Esposito
A pilot study on the efficacy, pharmacokinetics and safety of atazanavir in patients with end-stage liver disease.
The Journal of antimicrobial chemotherapy 2008;62(6):1356-64.
2008: Marco Siccardi; Antonio D'Avolio; Lorena Baietto; Sara Gibbons; Mauro Sciandra; Daniela Colucci; Stefano Bonora; Saye Khoo; David J Back; Giovanni Di Perri; Andrew Owen
Association of a single-nucleotide polymorphism in the pregnane X receptor (PXR 63396C-->T) with reduced concentrations of unboosted atazanavir.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;47(9):1222-5.
2008: Pauline Byakika-Kibwika; Mohammed Lamorde; Francis Kalemeera; Antonio D'Avolio; Sciandra Mauro; Giovanni Di Perri; Mairin Ryan; Harriet Mayanja-Kizza; Saye Khoo; David Back; Marta Boffito; Concepta Merry
Steady-state pharmacokinetic comparison of generic and branded formulations of stavudine, lamivudine and nevirapine in HIV-infected Ugandan adults.
The Journal of antimicrobial chemotherapy 2008;62(5):1113-7.
2008: Daniel Gonzalez de Requena; Stefano Bonora; Antonella Castagna; Hamid Hasson; Diego Aguilar Marucco; Antonio D'Avolio; Mauro Sciandra; Laura Trentini; Andrea Calcagno; Adriano Lazzarin; Giovanni Di Perri
Pharmacokinetic and pharmacodynamic determinants of early virological response to enfuvirtide-based regimens in HIV-positive patients.
The Journal of antimicrobial chemotherapy 2008;62(2):384-7.
2008: Antonio D'Avolio; Mauro Sciandra; Marco Siccardi; Lorena Baietto; Daniel Gonzalez de Requena; Stefano Bonora; Giovanni Di Perri
A new assay based on solid-phase extraction procedure with LC-MS to measure plasmatic concentrations of tenofovir and emtricitabine in HIV infected patients.
Journal of chromatographic science 2008;46(6):524-8.
2008: D Aguilar Marucco; D Gonzalez de Requena; Stefano Bonora; C Tettoni; M Bonasso; T De Blasi; Antonio D'Avolio; Mauro Sciandra; Marco Siccardi; L Baietto; Laura Trentini; Alessandro Sinicco; Giuseppe Cariti; Giovanni Di Perri
The use of trough ribavirin concentration to predict sustained virological response and haematological toxicity in HIV/HCV-co-infected patients treated with ribavirin and pegylated interferon.
The Journal of antimicrobial chemotherapy 2008;61(4):919-24.
2008: Daniel Gonzalez de Requena; Stefano Bonora; Andrea Calcagno; Antonio D'Avolio; Marco Siccardi; Silvia Fontana; Maria Grazia Milia; Mauro Sciandra; Silvia Garazzino; Antonio Di Garbo; Lorena Baietto; Laura Trentini; Giovanni Di Perri
Tipranavir (TPV) genotypic inhibitory quotient predicts virological response at 48 weeks to TPV-based salvage regimens.
Antimicrobial agents and chemotherapy 2008;52(3):1066-71.
2008: Antonio D'Avolio; Lorena Baietto; francesco giuseppe de rosa; Silvia Garazzino; Mauro Sciandra; Marco Siccardi; Stefano Bonora; Giovanni Di Perri
A simple and fast method for quantification of ertapenem using meropenem as internal standard in human plasma in a clinical setting.
Therapeutic drug monitoring 2008;30(1):90-4.
2008: Silvia Garazzino; Alessandro Aprato; Lorena Baietto; Antonio D'Avolio; Agostino Maiello; francesco giuseppe de rosa; Domenico Aloj; Marco Siccardi; Antonio Biasibetti; Alessandro Massè; Giovanni Di Perri
Glycopeptide bone penetration in patients with septic pseudoarthrosis of the tibia.
Clinical pharmacokinetics 2008;47(12):793-805.
2008: Paolo Maggi; Raffaele Filotico; Stefano Bonora; Anna Volpe; Chiara Bellacosa; Eliana Cinori; Daniel Gonzalez de Requena; Antonio D'Avolio; Giovanni Di Perri
Does iatrogenic scleroderma due to injection-site reaction to enfuvirtide impair absorption of the drug?
Clinical drug investigation 2008;28(5):305-11.
2008: Stefano Bonora; Massimiliano Lanzafame; Antonio D'Avolio; Laura Trentini; Emanuela Lattuada; Ercole Concia; Giovanni Di Perri
Drug interactions between warfarin and efavirenz or lopinavir-ritonavir in clinical treatment.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(1):146-7.
2007: Stefano Bonora; Andrea Calcagno; Silvia Fontana; Antonio D'Avolio; Marco Siccardi; Federico Gobbi; Giovanni Di Perri
Clinically significant drug interaction between tipranavir-ritonavir and phenobarbital in an HIV-infected subject.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(12):1654-5.
2007: Antonio D'Avolio; Marco Siccardi; Mauro Sciandra; Lorena Baietto; Baietto Lorena; Stefano Bonora; Laura Trentini; Giovanni Di Perri
HPLC-MS method for the simultaneous quantification of the new HIV protease inhibitor darunavir, and 11 other antiretroviral agents in plasma of HIV-infected patients.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2007;859(2):234-40.
2007: Antonio D'Avolio; Mauro Sciandra; Marco Siccardi; Lorena Baietto; Daniel Gonzalez de Requena; Stefano Bonora; Giovanni Di Perri
A simple and sensitive assay for determining plasma tipranavir concentration in the clinical setting by new HPLC method.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2007;848(2):374-8.
2007: Lauro J Waters; Graeme Moyle; Stefano Bonora; Antonio D'Avolio; Laura Else; Sundhiya Mandalia; Anton Pozniak; Mark Nelson; Brian Gazzard; David Back; Marta Boffito
Abacavir plasma pharmacokinetics in the absence and presence of atazanavir/ritonavir or lopinavir/ritonavir and vice versa in HIV-infected patients.
Antiviral therapy 2007;12(5):825-30.
2006: Daniel González de Requena; Andrea Calcagno; Stefano Bonora; Laura Ladetto; Antonio D'Avolio; Mauro Sciandra; Marco Siccardi; Olivia Bargiacchi; Alessandro Sinicco; Giovanni Di Perri
Unexpected drug-drug interaction between tipranavir/ritonavir and enfuvirtide.
AIDS (London, England) 2006;20(15):1977-9.
2006: Silvia Garazzino; M Tettoni; Andrea Calcagno; Antonio D'Avolio; Stefano Bonora; Giovanni Di Perri
Ritonavir-dependent fluconazole boosting of nelfinavir: a report of three cases.
The Journal of antimicrobial chemotherapy 2006;58(2):483-5.
2006: Antonio D'Avolio; Allende Ibañez; Mauro Sciandra; Marco Siccardi; Daniel Gonzalez de Requena; Stefano Bonora; Giovanni Di Perri
Validation of liquid/liquid extraction method coupled with HPLC-UV for measurement of ribavirin plasma levels in HCV-positive patients.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2006;835(1-2):127-30.
2006: Antonio D'Avolio; Mauro Sciandra; Daniel Gonzalez de Requena; Allende Ibañez; Stefano Bonora; Giovanni Di Perri
An improved HPLC fluorimetric method for the determination of enfuvirtide plasma levels in HIV-infected patients.
Therapeutic drug monitoring 2006;28(1):110-5.
2005: Daniel González de Requena; Stefano Bonora; Silvia Garazzino; Mauro Sciandra; Antonio D'Avolio; Riccardo Raiteri; R Marrone; Marta Boffito; francesco giuseppe de rosa; Alessandro Sinicco; Giovanni Di Perri
Nevirapine plasma exposure affects both durability of viral suppression and selection of nevirapine primary resistance mutations in a clinical setting.
Antimicrobial agents and chemotherapy 2005;49(9):3966-9.
2005: Francesca Canta; R Marrone; Stefano Bonora; Antonio D'Avolio; Mauro Sciandra; Alessandro Sinicco; francesco giuseppe de rosa; Giovanni Di Perri
Pharmacokinetics and hepatotoxicity of lopinavir/ritonavir in non-cirrhotic HIV and hepatitis C virus (HCV) co-infected patients.
The Journal of antimicrobial chemotherapy 2005;55(2):280-1.
2004: Stefano Bonora; Marta Boffito; Antonio D'Avolio; Mauro Sciandra; Anna Maria Caci; Francesca Conta; Alessandro Sinicco; francesco giuseppe de rosa; Giovanni Di Perri
Detection of stavudine concentrations in plasma of HIV-infected patients taking zidovudine.
AIDS (London, England) 2004;18(3):577-8.
2000: K Bosio; Claudio Avanzini; Antonio D'Avolio; O Ozino; Dianella Savoia
In vitro activity of propolis against Streptococcus pyogenes.
Letters in applied microbiology 2000;31(2):174-7.
1997: Franco Ghezzo; Graziella Berta; M Beccaro; Antonio D'Avolio; Silvia Racca; G Conti; Francesco Di Carlo
Calcyclin gene expression modulation by medroxyprogesterone acetate.
Biochemical pharmacology 1997;54(2):299-305.
1997: Graziella Berta; Franco Ghezzo; Antonio D'Avolio; P Zulian; V Carbone; Silvia Racca; V Vercellino; Francesco Di Carlo
Enhancement of calcyclin gene RNA expression in squamous cell carcinoma of the oral mucosa, but not in benign lesions.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1997;26(5):206-10.
1997: Franco Ghezzo; Silvia Racca; G Conti; Graziella Berta; Antonio D'Avolio; Giuliana Abbadessa; G Gambino; Francesco Di Carlo
L-histidine/medroxyprogesterone acetate interaction modulates human breast cancer cell growth and progestin receptor expression in vitro.
Pharmacological research : the official journal of the Italian Pharmacological Society 1997;35(2):119-22.